COVID-19 and asthma; What comments we need to know?

Javad Ghaffari, Abbas Dabbaghzadeh, Negar Ghaffari

DOI: 10.22122/cdj.v0i0.517

Abstract


BACKGROUND: Asthma is a common chronic inflammatory respiratory disease more common in children. Microbial agents such as viruses are a common trigger of asthma. Coronavirus disease 2019 (COVID-19) is a pandemic disease that could lead to the exacerbation of allergic disorders such as asthma. The aim of this study is to write a narrative review of COVID-19 and asthma condition.

METHODS: We searched in Google scholar, PubMed, and Scopus databases with keywords COVID-19, asthma, corticosteroid, and inhaled steroids.

RESULTS: We found a few original articles on the combined subject of asthma and COVID-19. More than 50% of our data is expert comments at valid websites such as https://www.AAAAI.org or https://ginasthma.org. The typical treatment recommended in the exacerbation of asthma or chronic obstructive pulmonary disease (COPD) included the use of corticosteroids. The routine use of corticosteroids in patients with COVID-19 without obstructive lung disease is not advised, as it may prolong viral replication.

CONCLUSION: Patients with asthma need to continue on their preventive asthma medication, such as inhaled corticosteroids (ICS) in pandemic COVID-19.


Keywords


COVID-19; Asthma; Therapeutics; Steroids

Full Text:

PDF

References


Lupia T, Scabini S, Mornese PS, Di Perri G, De Rosa FG, Corcione S. 2019 novel coronavirus (2019-nCoV) outbreak: A new challenge. J Glob Antimicrob Resist 2020; 21: 22-7.

Ghaffari J, Aarabi M. The prevalence of pediatric asthma in the Islamic Republic of Iran: A review and meta-analysis. J Pediatr Rev 2013; 1(1): 2-11.

Zamanfar D, Gaffari J, Behzadnia S, Yazdani-Charati J, Tavakoli S. The Prevalence of Allergic Rhinitis, Eczema and Asthma in Students of Guidance Schools in Mazandaran Province, Iran. Open Access Maced J Med Sci 2016; 4(4): 619-23.

Ghaffari J, Mohammadzadeh I, Khalilian A, Rafatpanah H, Mohammadjafari H, Davoudi A. Prevalence of asthma, allergic rhinitis and eczema in elementary schools in Sari (Iran). Caspian J Intern Med 2012; 3(1): 372-6.

Ghaffari J, Abbaskhanian A, Jalili M. IQ scores of children with moderate asthma: A comparison with healthy children. Oman Med J 2014; 29(1): 71-4.

Ghaffari J, Hadian A, Daneshpoor S, Khademloo M. Asthma burden in the hospitalized patients in north of Iran. Int J Pediatr 2014; 2(4): 257-66.

Hatami H, Ghaffari N, Ghaffari J, Rafatpanah H. Role of cytokines and chemokines in the outcome of children with severe Asthma. J Pediatr Rev 2019; 7(1): 17-28.

Aghajani M, Rafiei A, Ghaffari J, Valadan R, Kardan M. Immune dysregulation in children with allergic asthma, a close relationship between IL-17 but not IL-4 or IFN-g, and Disease Severity. Res Mol Med 2018; 6(1): 16-29.

Kardan M, Ghaffari J, Valadan R, Rafiei A, Soltani M, Aghajani M, et al. T-bet and GATA-3 Gene Expression in Children with Allergic Asthma and Healthy Controls. J Mazandaran Univ Med Sci 2017; 26(146): 9-21. [In Persian].

Farid Hossaini R, Ghaffari J, Ranjbar A, Haghshenas MR, Rafatpanah H. Infections in children with Asthma. J Pediatr Rev 2013; 1(1): 25-36.

Hartmann-Boyce J, Hobbs R. Inhaled steroids in Asthma during the COVID-19 Outbreak [Online]. [cited 2020]; Available from: URL:

https://www.cebm.net/covid-19/inhaled-steroids-in-asthma-during-the-covid-19-outbreak

Ghaffari J, Ashrafi H, Ranjbar AR, Nazari Z. Vitamin E in children with asthma: A review. J Pediatr Rev 2014; 2(2): 57-65.

Ghaffari J, Farid Hossiani R, Khalilian A, Nahanmoghadam N, Salehifar E, Rafatpanah H. Vitamin e supplementation, lung functions and clinical manifestations in children with moderate asthma: A randomized double blind placebo- controlled trial. Iran J Allergy Asthma Immunol 2014; 13(2): 98-103.

Global Initiative for Asthma (GINA). 2019 GINA Report, Global Strategy for Asthma Management and Prevention [Online]. [cited 2019]; Available from: URL: https://ginasthma.org/reports/2019-gina-report-global-strategy-for-asthma-management-and-prevention

American Academy of Allergy Asthma and Immunology (AAAAI). COVID-19 and Asthma: What patients need to know [Online]. [cited 2020]; Available from: URL:

https://www.aaaai.org/conditions-and-treatments/library/asthma-library/covid-asthma

Hartmann-Boyce J, Hobbs R. Inhaled Steroids in Asthma during the COVID-19 Outbreak [Online]. [cited 2020]; Available from: URL:

https://www.cebm.net/covid-19/inhaled-steroids-in-asthma-during-the-covid-19-outbreak/

Global Initiative for Asthma (GINA). COVID-19: GINA answers to frequently asked questions on asthma management [Online]. [cited 2020]; Available from: URL: https://ginasthma.org

Johnson K. Asthma Patients: Stay on steroids in face of COVID-19, Say Experts [Online]. [cited 2020]; Available from: URL:

https://www.medscape.com/viewarticle/927264

Wu F, Zhao S, Yu B, Chen YM, Wang W, Song ZG, et al. A new coronavirus associated with human respiratory disease in China. Nature 2020; 579(7798): 265-9.

Xu Z, Shi L, Wang Y, Zhang J, Huang L, Zhang C, et al. Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respir Med 2020; 8(4): 420-2.

Huang Y, Yang R, Xu Y, Gong P. Clinical characteristics of 36 non-survivors with COVID-19 in Wuhan, China [Online]. [cited 2020]; Available from: URL:

https://www.medrxiv.org/content/10.1101/2020.02.27.20029009v2

Matsuyama S, Kawase M, Nao N, Shirato K, Ujike M, Kamitani W, et al. The inhaled corticosteroid ciclesonide blocks coronavirus RNA replication by targeting viral NSP15 [Online]. [cited 2020]; Available from: URL:

https://www.biorxiv.org/content/10.1101/2020.03.11.987016v1

Zhang JJ, Dong X, Cao YY, Yuan YD, Yang YB, Yan YQ, et al. Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China. Allergy 2020.

Report on the Epidemiological Features of Coronavirus Disease 2019 (COVID-19) Outbreak in the Republic of Korea from January 19 to March 2, 2020. J Korean Med Sci 2020; 35(10): e112.

Huang K, Yang T, Xu J, Yang L, Zhao J, Zhang X, et al. Prevalence, risk factors, and management of asthma in China: A national cross-sectional study. Lancet 2019; 394(10196): 407-18.

Amirav I, Newhouse MT. Transmission of coronavirus by nebulizer: A serious, underappreciated risk. CMAJ 2020; 192(13): E346.

Desai M, Oppenheimer J, Lang DM. Immunomodulators and biologics: Beyond stepped-care therapy. Clin Chest Med 2019; 40(1): 179-92.

Denman S, Ford K, Toolan J, Mistry A, Corps C, Wood P, et al. Home self-administration of omalizumab for chronic spontaneous urticaria. Br J Dermatol 2016; 175(6): 1405-7.

Cowl C. Bending the curve': A pulmonologist's perspective on COVID-19 [Online]. [cited 2020]; Available from: URL:

https://www.healio.com/pulmonology/practice-management/news/online/%7B7d9f0bce-b191-45e0-a078-d95c51032324%7D/bending-the-curve-a-pulmonologists-perspective-on-covid-19

Shaker MS, Oppenheimer J, Grayson M, Stukus D, Hartog N, Hsieh EWY, et al. COVID-19: Pandemic contingency planning for the allergy and immunology clinic. J Allergy Clin Immunol Pract 2020.

Shaker MS, Oppenheimer J, Grayson M, Stukus D, Hartog N, Hsieh EW. COVID-19: Pandemic Contingency planning for the allergy and immunology clinic [Online]. [cited 2020]; Available from: URL:

https://education.aaaai.org/sites/default/files/COVID19_US%20FINAL.pdf

American Academy of Allergy Asthma and Immunology (AAAAI). COVID-19 and Asthma [Online]. [cited 2020]; Available from: URL; https://www.aaaai.org/ask-the-expert/19-asthma

Russell CD, Millar JE, Baillie JK. Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury. Lancet 2020; 395(10223): 473-5.

Zhao JP, Hu Y, Du RH, Chen ZS, Jin Y, Zhou M, et al. Expert consensus on the use of corticosteroid in patients with 2019-nCoV pneumonia. Zhonghua Jie He He Hu Xi Za Zhi 2020; 43(3): 183-4.

Singhal T. A review of coronavirus disease-2019 (COVID-19). Indian J Pediatr 2020; 87(4): 281-6.

Centers for Disease Control and Prevention.(CDC) Coronavirus (COVID-19) [Online]. [cited 2020]; Available from: URL:

https://www.cdc.gov/coronavirus/2019-ncov/index.html


Refbacks

  • There are currently no refbacks.


Creative Commons Attribution-NonCommercial 4.0

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 Unported License which allows users to read, copy, distribute and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited properly.